Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W BURKE

Showing results (161-170 of 1,093) with videos related to

Pageof 110
Sort By:
Gynecologic Oncology|August 21, 2003
Arzoxifene as therapy for endometrial cancerThomas W Burke, Cheryl L Walker
The Proceedings of the Nutrition Society|April 20, 2001
Iron deficiency and iron overload: effects of diet and genesW Burke, G Imperatore, M Reyes
Journal of Dental Research|July 1, 1971
Diurnal variation in DNA synthesis in hamster oral epitheliumM C England, G W Burke
Talanta|April 1, 1970
Simultaneous spectrophotometric determination of cobalt, nickel and copper with 2,3-quinoxaline- dithiolR W Burke, E R Deardorff
The Quarterly Journal of Medicine|January 1, 1973
Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosisC W Burke, C G Beardwell
British Journal of Neurosurgery|January 1, 1993
Current modes of treatment of pituitary tumoursC B Adams, C W Burke
Clinical Obstetrics and Gynecology|September 1, 1996
Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinomaT W Burke, D M Gershenson
Genes & Development|March 15, 1996
Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promotersT W Burke, J T Kadonaga
Journal of the Royal Society of Medicine|August 1, 1986
Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndromeD J Evans, C W Burke
Clinical Endocrinology|November 1, 1986
Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptineJ S Bevan, C W Burke
Pageof 110

Showing results (161-170 of 1,093) with videos related to

Sort By:
Pageof 110
Gynecologic Oncology|August 21, 2003
Arzoxifene as therapy for endometrial cancerThomas W Burke, Cheryl L Walker
The Proceedings of the Nutrition Society|April 20, 2001
Iron deficiency and iron overload: effects of diet and genesW Burke, G Imperatore, M Reyes
Journal of Dental Research|July 1, 1971
Diurnal variation in DNA synthesis in hamster oral epitheliumM C England, G W Burke
Talanta|April 1, 1970
Simultaneous spectrophotometric determination of cobalt, nickel and copper with 2,3-quinoxaline- dithiolR W Burke, E R Deardorff
The Quarterly Journal of Medicine|January 1, 1973
Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosisC W Burke, C G Beardwell
British Journal of Neurosurgery|January 1, 1993
Current modes of treatment of pituitary tumoursC B Adams, C W Burke
Clinical Obstetrics and Gynecology|September 1, 1996
Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinomaT W Burke, D M Gershenson
Genes & Development|March 15, 1996
Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promotersT W Burke, J T Kadonaga
Journal of the Royal Society of Medicine|August 1, 1986
Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndromeD J Evans, C W Burke
Clinical Endocrinology|November 1, 1986
Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptineJ S Bevan, C W Burke
Pageof 110